Data Reporting, Compliance and Integrity – Webinars and Online Events

Speaking at Cell & Gene Therapy 2023, Kevin Holden, PhD from Synthego, presented their talk on synthesizing CRISPR guide RNAs.

Most organizations now recognize digitalization as a necessity for the lab of the future, yet many find it difficult to justify the expense, get stakeholder buy-in, or move the process forward. The delay carries significant risks – anything from untraceable data, lost protocols, to non-compliance of regulatory requirements on data integrity. It also takes away the opportunities to automate, scale up, and integrate lab processes efficiently.

When it comes to lab efficiency and compliance: it’s all about the basics and the basics of any modern lab are digital. This means choosing the right software tools to ensure data integrity while increasing efficiency and guaranteeing compliance. Your balances and tools have to support the right applications (e.g. weighing, pipette checks) and be open to managing information about third party instruments. Also, to minimize qualification efforts, novel software tools need to be modular. Modularity ensures that users can expand and update software capabilities without affecting the functionalities of separate modules. To discover how novel digital solutions can eliminate manual data management steps when it comes to your balances, resulting in increased lab efficiency while ensuring compliance, sign up now!

Join us for an exclusive webinar focused on psilocybin licensing and compliance with expert speaker Ryan Pincura, Director of Regulatory Affairs at Tendrel Group.

Developing a small molecule active pharmaceutical ingredient (API) is often a risky process. Reaching the goal, be it first in human studies or commercial manufacture, requires data and material without incurring unnecessary delays or impact on costs. Therefore, it’s important to start thinking about process steps and scalability early.

The rapid increase in CRISPR-mediated cell and gene therapies in clinical trials over the past few years is a testimony to the promising future of next-generation medicine.

A major concern for those intending to bring cell and gene therapy products to market is the manufacturing needs as the product moves from small- to large-scale.

In this third and final part of our translational cell and gene therapy webinar series we delve into cell therapy applications beyond immune oncology.

Do you want to bring your CAR NK cell and Treg cell research into clinical applications?

Watch this webinar and explore Miltenyi Biotec’s solutions to advance CAR NK cell and Treg-based therapies – from basic research to process development and clinical manufacturing. Discover the products, tools and services that build on Miltenyi Biotec’s expertise to move your CAR NK and Treg projects forward.

Attend this webinar to learn about:
- Discover opportunities that exist in clinical research testing for protein biomarkers (particularly in cardiovascular disease)
- Learn the advantages in performing protein quantification at higher flow rates
- Understand the considerations for implementing an LC-MS analysis for protein biomarker quantification in a clinical translational context